Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Enliven Therapeutics, Inc. (IMRA)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | S-1/A |
| Revenues | | | 100.0% |
| Cost of goods sold | | | 129.6% |
| Gross profit | | | -29.6% |
| General and administrative | | | 29.6% |
| EBIT | | | -129.6% |
| Pre-tax income | | | -137.6% |
| Income taxes | | | 0.0% |
| Net income | | | -137.6% |
|